Results 1 to 10 of about 354,756 (297)
Transverse and Sigmoid Venous Sinus Thrombosis Associated with Nephrotic Syndrome [PDF]
A 6 years old female diagnosed with nephrotic syndrome developed, during her first admission in the hospital, sinus transvers thrombosis. At first it was considered a complication of the disease, but later it was proved that she had hereditary ...
Anca CROITORU, Mihaela BALGRADEAN
doaj +1 more source
THE SUITABLE ANTICOAGULANT, TIME AND TEMPERATURE FOR BLOOD SAMPLE COLLECTION [PDF]
The blood is a connective tissue that composes of suspended cells in liquidmatrix. In this study ,we discuss the effect of three factors on blood sampling duringthe collection of blood samples (anti-coagulants, temperature and duration of storage).
Adel M. Al zobidy +2 more
doaj +1 more source
Comparison of circuit patency and exchange rates between the original and generic versions of nafamostat mesylate in critically ill adults receiving continuous renal replacement therapy [PDF]
Background Nafamostat mesylate is widely used as an anticoagulant in continuous renal replacement therapy (CRRT). The generic versions of nafamostat mesylate have identical main components to the original product.
Sujung Heo +6 more
doaj +1 more source
Atrial fibrillation in elderly patients. Features of using rivaroxaban
The problem of anticoagulant treatment of elderly patients with atrial fibrillation (AF) is very topical for everyday medical practice because, on the one hand, the proportion of elderly patients among those who have AF is constantly increasing, and, on ...
A. D. Erlikh
doaj +1 more source
Anticoagulant status under COVID-19: The potential pathophysiological mechanism
Coronavirus disease 19 (COVID-19) is a systematic multitropic disease. Sustaining blood homeostasis is a mission of multiple factors includes procoagulant and anticoagulant systems.
Basheer Abdullah Marzoog
doaj +1 more source
Experimental antithrombotic effect of medicinal plants: A critical review
Thrombosis is one of the major causes of morbidity and mortality in a wide range of cardiovascular disorders (CVDs). CVDs are listed among top ten killer diseases. Antithrombotic drugs reduce the incidence of cardiovascular events about 20%–25% in people.
Shweta Mandloi +2 more
doaj +1 more source
Background: The Novel Oral Anticoagulants (NOACs), despite numerous benefits, such as the ease of use and less drug involvement, provide extensive adverse effects.
Abbas Ghaysouri +2 more
doaj +1 more source
Heparin Mimetics: Their Therapeutic Potential
Heparin mimetics are synthetic and semi-synthetic compounds that are highly sulfated, structurally distinct analogues of glycosaminoglycans. These mimetics are often rationally designed to increase potency and binding selectivity towards specific ...
Shifaza Mohamed, Deirdre R. Coombe
doaj +1 more source
Vitamin K epoxide reductase (VKOR) is a target enzyme for anticoagulants, such as warfarin, that are used as medicines or rodenticides. Assessing VKOR activity is required to ensure the proper usage of these drugs.
Kazuki Takeda +4 more
doaj +1 more source
Life‐threatening extrapleural hematoma in an anticoagulated patient 2 weeks after lobectomy
We report a case of an anticoagulated patient with sudden onset pleural hematoma after straining at defecation to cardiac arrest on 2 weeks after lobectomy for lung cancer.
Masanori Shimomura +3 more
doaj +1 more source

